Search This Blog

Thursday, August 23, 2018

Cantor Fitzgerald Starts Reata Pharmaceuticals (RETA) at Overweight


Cantor Fitzgerald analyst Charles Duncan initiates coverage on Reata Pharmaceuticals.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)